Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Human Insulin Market 2018, Forecast to 2023
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
Scope of the Report:
This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
The worldwide market for Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Human Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Insulin, with sales, revenue, and price of Human Insulin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Insulin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
The worldwide market for Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- B. Braun
- Becton, Dickinson
- Biocon
- Biodel
- ELI Lilly
- Julphar
- NOVO Nordisk
- Sanofi
- Wockhardt
- Ypsomed
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Insulin Analogs and Biosimilars
- Human Insulin Biologics
- Short acting
- Intermediate acting
- Long acting
- Pre-mix Insulin
Chapter 1, to describe Human Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Insulin, with sales, revenue, and price of Human Insulin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Insulin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Insulin Analogs and Biosimilars
1.2.2 Human Insulin Biologics
1.3 Market Analysis by Applications
1.3.1 Short acting
1.3.2 Intermediate acting
1.3.3 Long acting
1.3.4 Pre-mix Insulin
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 B. Braun
2.1.1 Business Overview
2.1.1.1 B. Braun Description
2.1.1.2 B. Braun Headquarter, Main Business and Finance Overview
2.1.2 B. Braun Human Insulin Product Introduction
2.1.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.1.2.2 Human Insulin Product Information
2.1.3 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global B. Braun Human Insulin Market Share in 2017
2.2 Becton, Dickinson
2.2.1 Business Overview
2.2.1.1 Becton, Dickinson Description
2.2.1.2 Becton, Dickinson Headquarter, Main Business and Finance Overview
2.2.2 Becton, Dickinson Human Insulin Product Introduction
2.2.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.2.2.2 Human Insulin Product Information
2.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Becton, Dickinson Human Insulin Market Share in 2017
2.3 Biocon
2.3.1 Business Overview
2.3.1.1 Biocon Description
2.3.1.2 Biocon Headquarter, Main Business and Finance Overview
2.3.2 Biocon Human Insulin Product Introduction
2.3.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.3.2.2 Human Insulin Product Information
2.3.3 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Biocon Human Insulin Market Share in 2017
2.4 Biodel
2.4.1 Business Overview
2.4.1.1 Biodel Description
2.4.1.2 Biodel Headquarter, Main Business and Finance Overview
2.4.2 Biodel Human Insulin Product Introduction
2.4.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.4.2.2 Human Insulin Product Information
2.4.3 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Biodel Human Insulin Market Share in 2017
2.5 ELI Lilly
2.5.1 Business Overview
2.5.1.1 ELI Lilly Description
2.5.1.2 ELI Lilly Headquarter, Main Business and Finance Overview
2.5.2 ELI Lilly Human Insulin Product Introduction
2.5.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.5.2.2 Human Insulin Product Information
2.5.3 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global ELI Lilly Human Insulin Market Share in 2017
2.6 Julphar
2.6.1 Business Overview
2.6.1.1 Julphar Description
2.6.1.2 Julphar Headquarter, Main Business and Finance Overview
2.6.2 Julphar Human Insulin Product Introduction
2.6.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.6.2.2 Human Insulin Product Information
2.6.3 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Julphar Human Insulin Market Share in 2017
2.7 NOVO Nordisk
2.7.1 Business Overview
2.7.1.1 NOVO Nordisk Description
2.7.1.2 NOVO Nordisk Headquarter, Main Business and Finance Overview
2.7.2 NOVO Nordisk Human Insulin Product Introduction
2.7.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.7.2.2 Human Insulin Product Information
2.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global NOVO Nordisk Human Insulin Market Share in 2017
2.8 Sanofi
2.8.1 Business Overview
2.8.1.1 Sanofi Description
2.8.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Human Insulin Product Introduction
2.8.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.8.2.2 Human Insulin Product Information
2.8.3 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Human Insulin Market Share in 2017
2.9 Wockhardt
2.9.1 Business Overview
2.9.1.1 Wockhardt Description
2.9.1.2 Wockhardt Headquarter, Main Business and Finance Overview
2.9.2 Wockhardt Human Insulin Product Introduction
2.9.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.9.2.2 Human Insulin Product Information
2.9.3 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Wockhardt Human Insulin Market Share in 2017
2.10 Ypsomed
2.10.1 Business Overview
2.10.1.1 Ypsomed Description
2.10.1.2 Ypsomed Headquarter, Main Business and Finance Overview
2.10.2 Ypsomed Human Insulin Product Introduction
2.10.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.10.2.2 Human Insulin Product Information
2.10.3 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Ypsomed Human Insulin Market Share in 2017
3 GLOBAL HUMAN INSULIN MARKET COMPETITION, BY MANUFACTURER
3.1 Global Human Insulin Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Human Insulin Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Insulin Manufacturer Market Share in 2017
3.4.2 Top 5 Human Insulin Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL HUMAN INSULIN MARKET ANALYSIS BY REGIONS
4.1 Global Human Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Insulin Sales by Regions (2013-2018)
4.1.2 Global Human Insulin Revenue by Regions (2013-2018)
4.2 North America Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Insulin Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Human Insulin Sales, Revenue and Market Share by Countries
5.1.1 North America Human Insulin Sales by Countries (2013-2018)
5.1.2 North America Human Insulin Revenue by Countries (2013-2018)
5.1.3 United States Human Insulin Sales and Growth Rate (2013-2018)
5.1.4 Canada Human Insulin Sales and Growth Rate (2013-2018)
5.1.5 Mexico Human Insulin Sales and Growth Rate (2013-2018)
5.2 North America Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Human Insulin Sales by Manufacturers (2016-2017)
5.2.2 North America Human Insulin Revenue by Manufacturers (2016-2017)
5.3 North America Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Human Insulin Sales and Sales Share by Type (2013-2018)
5.3.2 North America Human Insulin Revenue and Revenue Share by Type (2013-2018)
5.4 North America Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Human Insulin Sales and Sales Share by Application (2013-2018)
5.4.2 North America Human Insulin Revenue and Revenue Share by Application (2013-2018)
6 EUROPE HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Human Insulin Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Insulin Sales by Countries (2013-2018)
6.1.2 Europe Human Insulin Revenue by Countries (2013-2018)
6.1.3 Germany Human Insulin Sales and Growth Rate (2013-2018)
6.1.4 UK Human Insulin Sales and Growth Rate (2013-2018)
6.1.5 France Human Insulin Sales and Growth Rate (2013-2018)
6.1.6 Russia Human Insulin Sales and Growth Rate (2013-2018)
6.1.7 Italy Human Insulin Sales and Growth Rate (2013-2018)
6.2 Europe Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Human Insulin Sales by Manufacturers (2016-2017)
6.2.2 Europe Human Insulin Revenue by Manufacturers (2016-2017)
6.3 Europe Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Human Insulin Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Human Insulin Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Human Insulin Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Human Insulin Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Insulin Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Human Insulin Revenue by Countries (2013-2018)
7.1.3 China Human Insulin Sales and Growth Rate (2013-2018)
7.1.4 Japan Human Insulin Sales and Growth Rate (2013-2018)
7.1.5 Korea Human Insulin Sales and Growth Rate (2013-2018)
7.1.6 India Human Insulin Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Human Insulin Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Human Insulin Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Human Insulin Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Human Insulin Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Human Insulin Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Human Insulin Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Human Insulin Sales, Revenue and Market Share by Countries
8.1.1 South America Human Insulin Sales by Countries (2013-2018)
8.1.2 South America Human Insulin Revenue by Countries (2013-2018)
8.1.3 Brazil Human Insulin Sales and Growth Rate (2013-2018)
8.1.4 Argentina Human Insulin Sales and Growth Rate (2013-2018)
8.1.5 Colombia Human Insulin Sales and Growth Rate (2013-2018)
8.2 South America Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Human Insulin Sales by Manufacturers (2016-2017)
8.2.2 South America Human Insulin Revenue by Manufacturers (2016-2017)
8.3 South America Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Human Insulin Sales and Sales Share by Type (2013-2018)
8.3.2 South America Human Insulin Revenue and Revenue Share by Type (2013-2018)
8.4 South America Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Human Insulin Sales and Sales Share by Application (2013-2018)
8.4.2 South America Human Insulin Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Insulin Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Human Insulin Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)
9.1.4 UAE Human Insulin Sales and Growth Rate (2013-2018)
9.1.5 Egypt Human Insulin Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Human Insulin Sales and Growth Rate (2013-2018)
9.1.7 South Africa Human Insulin Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Human Insulin Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Human Insulin Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Human Insulin Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Human Insulin Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Human Insulin Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Human Insulin Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL HUMAN INSULIN MARKET SEGMENT BY TYPE
10.1 Global Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Insulin Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)
10.2 Insulin Analogs and Biosimilars Sales Growth and Price
10.2.1 Global Insulin Analogs and Biosimilars Sales Growth (2013-2018)
10.2.2 Global Insulin Analogs and Biosimilars Price (2013-2018)
10.3 Human Insulin Biologics Sales Growth and Price
10.3.1 Global Human Insulin Biologics Sales Growth (2013-2018)
10.3.2 Global Human Insulin Biologics Price (2013-2018)
11 GLOBAL HUMAN INSULIN MARKET SEGMENT BY APPLICATION
11.1 Global Human Insulin Sales Market Share by Application (2013-2018)
11.2 Short acting Sales Growth (2013-2018)
11.3 Intermediate acting Sales Growth (2013-2018)
11.4 Long acting Sales Growth (2013-2018)
11.5 Pre-mix Insulin Sales Growth (2013-2018)
12 HUMAN INSULIN MARKET FORECAST (2018-2023)
12.1 Global Human Insulin Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Insulin Market Forecast by Regions (2018-2023)
12.2.1 North America Human Insulin Market Forecast (2018-2023)
12.2.2 Europe Human Insulin Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Insulin Market Forecast (2018-2023)
12.2.4 South America Human Insulin Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Insulin Market Forecast (2018-2023)
12.3 Human Insulin Market Forecast by Type (2018-2023)
12.3.1 Global Human Insulin Sales Forecast by Type (2018-2023)
12.3.2 Global Human Insulin Market Share Forecast by Type (2018-2023)
12.4 Human Insulin Market Forecast by Application (2018-2023)
12.4.1 Global Human Insulin Sales Forecast by Application (2018-2023)
12.4.2 Global Human Insulin Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Insulin Analogs and Biosimilars
1.2.2 Human Insulin Biologics
1.3 Market Analysis by Applications
1.3.1 Short acting
1.3.2 Intermediate acting
1.3.3 Long acting
1.3.4 Pre-mix Insulin
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 B. Braun
2.1.1 Business Overview
2.1.1.1 B. Braun Description
2.1.1.2 B. Braun Headquarter, Main Business and Finance Overview
2.1.2 B. Braun Human Insulin Product Introduction
2.1.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.1.2.2 Human Insulin Product Information
2.1.3 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global B. Braun Human Insulin Market Share in 2017
2.2 Becton, Dickinson
2.2.1 Business Overview
2.2.1.1 Becton, Dickinson Description
2.2.1.2 Becton, Dickinson Headquarter, Main Business and Finance Overview
2.2.2 Becton, Dickinson Human Insulin Product Introduction
2.2.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.2.2.2 Human Insulin Product Information
2.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Becton, Dickinson Human Insulin Market Share in 2017
2.3 Biocon
2.3.1 Business Overview
2.3.1.1 Biocon Description
2.3.1.2 Biocon Headquarter, Main Business and Finance Overview
2.3.2 Biocon Human Insulin Product Introduction
2.3.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.3.2.2 Human Insulin Product Information
2.3.3 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Biocon Human Insulin Market Share in 2017
2.4 Biodel
2.4.1 Business Overview
2.4.1.1 Biodel Description
2.4.1.2 Biodel Headquarter, Main Business and Finance Overview
2.4.2 Biodel Human Insulin Product Introduction
2.4.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.4.2.2 Human Insulin Product Information
2.4.3 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Biodel Human Insulin Market Share in 2017
2.5 ELI Lilly
2.5.1 Business Overview
2.5.1.1 ELI Lilly Description
2.5.1.2 ELI Lilly Headquarter, Main Business and Finance Overview
2.5.2 ELI Lilly Human Insulin Product Introduction
2.5.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.5.2.2 Human Insulin Product Information
2.5.3 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global ELI Lilly Human Insulin Market Share in 2017
2.6 Julphar
2.6.1 Business Overview
2.6.1.1 Julphar Description
2.6.1.2 Julphar Headquarter, Main Business and Finance Overview
2.6.2 Julphar Human Insulin Product Introduction
2.6.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.6.2.2 Human Insulin Product Information
2.6.3 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Julphar Human Insulin Market Share in 2017
2.7 NOVO Nordisk
2.7.1 Business Overview
2.7.1.1 NOVO Nordisk Description
2.7.1.2 NOVO Nordisk Headquarter, Main Business and Finance Overview
2.7.2 NOVO Nordisk Human Insulin Product Introduction
2.7.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.7.2.2 Human Insulin Product Information
2.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global NOVO Nordisk Human Insulin Market Share in 2017
2.8 Sanofi
2.8.1 Business Overview
2.8.1.1 Sanofi Description
2.8.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Human Insulin Product Introduction
2.8.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.8.2.2 Human Insulin Product Information
2.8.3 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Human Insulin Market Share in 2017
2.9 Wockhardt
2.9.1 Business Overview
2.9.1.1 Wockhardt Description
2.9.1.2 Wockhardt Headquarter, Main Business and Finance Overview
2.9.2 Wockhardt Human Insulin Product Introduction
2.9.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.9.2.2 Human Insulin Product Information
2.9.3 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Wockhardt Human Insulin Market Share in 2017
2.10 Ypsomed
2.10.1 Business Overview
2.10.1.1 Ypsomed Description
2.10.1.2 Ypsomed Headquarter, Main Business and Finance Overview
2.10.2 Ypsomed Human Insulin Product Introduction
2.10.2.1 Human Insulin Production Bases, Sales Regions and Major Competitors
2.10.2.2 Human Insulin Product Information
2.10.3 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Ypsomed Human Insulin Market Share in 2017
3 GLOBAL HUMAN INSULIN MARKET COMPETITION, BY MANUFACTURER
3.1 Global Human Insulin Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Human Insulin Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Insulin Manufacturer Market Share in 2017
3.4.2 Top 5 Human Insulin Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL HUMAN INSULIN MARKET ANALYSIS BY REGIONS
4.1 Global Human Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Insulin Sales by Regions (2013-2018)
4.1.2 Global Human Insulin Revenue by Regions (2013-2018)
4.2 North America Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Human Insulin Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Insulin Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Human Insulin Sales, Revenue and Market Share by Countries
5.1.1 North America Human Insulin Sales by Countries (2013-2018)
5.1.2 North America Human Insulin Revenue by Countries (2013-2018)
5.1.3 United States Human Insulin Sales and Growth Rate (2013-2018)
5.1.4 Canada Human Insulin Sales and Growth Rate (2013-2018)
5.1.5 Mexico Human Insulin Sales and Growth Rate (2013-2018)
5.2 North America Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Human Insulin Sales by Manufacturers (2016-2017)
5.2.2 North America Human Insulin Revenue by Manufacturers (2016-2017)
5.3 North America Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Human Insulin Sales and Sales Share by Type (2013-2018)
5.3.2 North America Human Insulin Revenue and Revenue Share by Type (2013-2018)
5.4 North America Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Human Insulin Sales and Sales Share by Application (2013-2018)
5.4.2 North America Human Insulin Revenue and Revenue Share by Application (2013-2018)
6 EUROPE HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Human Insulin Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Insulin Sales by Countries (2013-2018)
6.1.2 Europe Human Insulin Revenue by Countries (2013-2018)
6.1.3 Germany Human Insulin Sales and Growth Rate (2013-2018)
6.1.4 UK Human Insulin Sales and Growth Rate (2013-2018)
6.1.5 France Human Insulin Sales and Growth Rate (2013-2018)
6.1.6 Russia Human Insulin Sales and Growth Rate (2013-2018)
6.1.7 Italy Human Insulin Sales and Growth Rate (2013-2018)
6.2 Europe Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Human Insulin Sales by Manufacturers (2016-2017)
6.2.2 Europe Human Insulin Revenue by Manufacturers (2016-2017)
6.3 Europe Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Human Insulin Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Human Insulin Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Human Insulin Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Human Insulin Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Insulin Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Human Insulin Revenue by Countries (2013-2018)
7.1.3 China Human Insulin Sales and Growth Rate (2013-2018)
7.1.4 Japan Human Insulin Sales and Growth Rate (2013-2018)
7.1.5 Korea Human Insulin Sales and Growth Rate (2013-2018)
7.1.6 India Human Insulin Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Human Insulin Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Human Insulin Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Human Insulin Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Human Insulin Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Human Insulin Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Human Insulin Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Human Insulin Sales, Revenue and Market Share by Countries
8.1.1 South America Human Insulin Sales by Countries (2013-2018)
8.1.2 South America Human Insulin Revenue by Countries (2013-2018)
8.1.3 Brazil Human Insulin Sales and Growth Rate (2013-2018)
8.1.4 Argentina Human Insulin Sales and Growth Rate (2013-2018)
8.1.5 Colombia Human Insulin Sales and Growth Rate (2013-2018)
8.2 South America Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Human Insulin Sales by Manufacturers (2016-2017)
8.2.2 South America Human Insulin Revenue by Manufacturers (2016-2017)
8.3 South America Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Human Insulin Sales and Sales Share by Type (2013-2018)
8.3.2 South America Human Insulin Revenue and Revenue Share by Type (2013-2018)
8.4 South America Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Human Insulin Sales and Sales Share by Application (2013-2018)
8.4.2 South America Human Insulin Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA HUMAN INSULIN BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Insulin Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Human Insulin Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)
9.1.4 UAE Human Insulin Sales and Growth Rate (2013-2018)
9.1.5 Egypt Human Insulin Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Human Insulin Sales and Growth Rate (2013-2018)
9.1.7 South Africa Human Insulin Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Human Insulin Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Human Insulin Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Human Insulin Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Human Insulin Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Human Insulin Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Human Insulin Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Human Insulin Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL HUMAN INSULIN MARKET SEGMENT BY TYPE
10.1 Global Human Insulin Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Insulin Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)
10.2 Insulin Analogs and Biosimilars Sales Growth and Price
10.2.1 Global Insulin Analogs and Biosimilars Sales Growth (2013-2018)
10.2.2 Global Insulin Analogs and Biosimilars Price (2013-2018)
10.3 Human Insulin Biologics Sales Growth and Price
10.3.1 Global Human Insulin Biologics Sales Growth (2013-2018)
10.3.2 Global Human Insulin Biologics Price (2013-2018)
11 GLOBAL HUMAN INSULIN MARKET SEGMENT BY APPLICATION
11.1 Global Human Insulin Sales Market Share by Application (2013-2018)
11.2 Short acting Sales Growth (2013-2018)
11.3 Intermediate acting Sales Growth (2013-2018)
11.4 Long acting Sales Growth (2013-2018)
11.5 Pre-mix Insulin Sales Growth (2013-2018)
12 HUMAN INSULIN MARKET FORECAST (2018-2023)
12.1 Global Human Insulin Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Insulin Market Forecast by Regions (2018-2023)
12.2.1 North America Human Insulin Market Forecast (2018-2023)
12.2.2 Europe Human Insulin Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Insulin Market Forecast (2018-2023)
12.2.4 South America Human Insulin Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Insulin Market Forecast (2018-2023)
12.3 Human Insulin Market Forecast by Type (2018-2023)
12.3.1 Global Human Insulin Sales Forecast by Type (2018-2023)
12.3.2 Global Human Insulin Market Share Forecast by Type (2018-2023)
12.4 Human Insulin Market Forecast by Application (2018-2023)
12.4.1 Global Human Insulin Sales Forecast by Application (2018-2023)
12.4.2 Global Human Insulin Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Human Insulin Picture
Table Product Specifications of Human Insulin
Figure Global Human Insulin CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Human Insu
Figure Human Insulin Picture
Table Product Specifications of Human Insulin
Figure Global Human Insulin CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Human Insu
